Michal Štros
Impact in
- Clinical Biochemistry top 0.5%
- Advanced Glycation End Products research
- Immunology top 10%
- Immune Response and Inflammation
Papers in
-
- DNA and Nucleic Acid Chemistry 14
- RNA and protein synthesis mechanisms 10
- Genomics and Chromatin Dynamics 9
- DNA Repair Mechanisms 5
- RNA Interference and Gene Delivery 5
- Epigenetics and DNA Methylation 4
- Oncology 10
- Drug Transport and Resistance Mechanisms 8
- Co-authors
- Dorte Launholt (1 shared paper)Klaus D. Grasser (1 shared paper)Jitka Štokrová (2 shared papers)Jean Thomas (1 shared paper)Šárka Pospı́šilová (4 shared papers)Akira Nakagawara (1 shared paper)Toshinori Ozaki (1 shared paper)Hajime Kageyama (1 shared paper)
In The Last Decade
Michal Štros
36 papers receiving 1.9k citations
Michal Štros's Hit Papers
Peers
Comparison fields: 5 of 96
- Clinical Biochemistry 617
- Immunology 375
- Molecular Biology 1.2k
- Oncology 292
- Cancer Research 148
Countries citing papers authored by Michal Štros
This map shows the geographic impact of Michal Štros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michal Štros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michal Štros more than expected).
Fields of papers citing papers by Michal Štros
This network shows the impact of papers produced by Michal Štros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michal Štros. The network helps show where Michal Štros may publish in the future.
Co-authors
The 25 scholars most cited alongside Michal Štros, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | HMGB proteins: Interactions with DNA and chromatin Hit paper breakdown → | 2010 | 501 |
| 2 | 2007 | 235 | |
| 3 | 2002 | 163 | |
| 4 | 1994 | 129 | |
| 5 | 1998 | 105 | |
| 6 | Fludarabine triphosphate inhibits nucleotide excision repair of cisplatin-induced DNA adducts in vitro. | 1997 | 62 |
| 7 | 2012 | 61 | |
| 8 | 2004 | 60 | |
| 9 | 2000 | 50 | |
| 10 | 2000 | 43 | |
| 11 | 2009 | 42 | |
| 12 | 2001 | 39 | |
| 13 | 1994 | 38 | |
| 14 | 2003 | 34 | |
| 15 | 2007 | 33 | |
| 16 | 2005 | 33 | |
| 17 | 1998 | 32 | |
| 18 | 2014 | 28 | |
| 19 | 2018 | 27 | |
| 20 | 1993 | 23 |
About Michal Štros
Michal Štros is a scholar working on Molecular Biology, Oncology, Clinical Biochemistry, Physiology and Immunology, having authored 36 papers that have together received 1.9k indexed citations. Recurring topics across this work include DNA and Nucleic Acid Chemistry (14 papers), RNA and protein synthesis mechanisms (10 papers), Advanced Glycation End Products research (9 papers), Genomics and Chromatin Dynamics (9 papers), Drug Transport and Resistance Mechanisms (8 papers), DNA Repair Mechanisms (5 papers), RNA Interference and Gene Delivery (5 papers) and Epigenetics and DNA Methylation (4 papers). The work is most often cited by research in Clinical Biochemistry (617 citations), Immunology (375 citations), Molecular Biology (1.2k citations), Oncology (292 citations) and Cancer Research (148 citations). Michal Štros has collaborated with scholars based in Czechia, France and Canada. Frequent co-authors include Dorte Launholt, Klaus D. Grasser, Jitka Štokrová, Jean Thomas, Šárka Pospı́šilová, Akira Nakagawara, Toshinori Ozaki, Hajime Kageyama, Alena Bačı́ková and François Strauss. Their work appears in journals such as Biochemistry, European Journal of Biochemistry, Nucleic Acids Research, Journal of Biological Chemistry and Gene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.